Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases

Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases

US Patent 9877958 · Granted Jan 30, 2018

Estimated economic value: $149,887,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tricyclic compounds as inhibitors of KRAS2025
Naphthyridine compounds as inhibitors of KRAS2025
SLAM polynucleotides and polypeptides and uses thereof2025
1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibi2024
1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibi2024
1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibi2024
Fluorescent PCR method for detecting HLA-B*15:02 allele and specific primer prob2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024